Biotechnology
The Biotechnology industry has a total of 611 stocks, with a combined market cap of $1.06 trillion and total revenue of $105.45 billion.
Market Cap
1.06T
Revenue
105.45B
Profits
-42.78B
PE Ratio
n/a
Profit Margin
-40.57%
Dividend Yield
0.04%
611 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 107.98B | 1.08% | 468,685 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 75.78B | 5.10% | 1,427,753 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 59.36B | -2.48% | 359,375 | 3.21B |
| 4 | ARGX | argenx SE | 56.30B | 0.26% | 173,058 | 3.68B |
| 5 | INSM | Insmed Incorporated | 43.23B | -0.42% | 1,071,089 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 39.16B | 0.03% | 104,623 | 5.00B |
| 7 | BNTX | BioNTech SE | 23.82B | -2.33% | 596,468 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.04B | -1.22% | 995,051 | 2.35B |
| 9 | INCY | Incyte Corporation | 19.92B | 0.14% | 664,093 | 4.81B |
| 10 | GMAB | Genmab A/S | 18.82B | -1.47% | 587,034 | 3.85B |
| 11 | ROIV | Roivant Sciences Ltd. | 14.09B | -0.39% | 2,630,757 | 20.33M |
| 12 | RVMD | Revolution Medicines, Inc. | 13.63B | -0.07% | 1,076,423 | - |
| 13 | ASND | Ascendis Pharma A/S | 12.82B | -1.11% | 171,604 | 758.59M |
| 14 | BBIO | BridgeBio Pharma, Inc. | 12.66B | 0.27% | 1,235,054 | 353.78M |
| 15 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.44B | -1.45% | 151,817 | 740.64M |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 12.09B | 0.86% | 1,432,170 | 966.96M |
| 17 | SMMT | Summit Therapeutics Inc. | 11.95B | -3.08% | 1,312,312 | - |
| 18 | EXEL | Exelixis, Inc. | 11.25B | -0.83% | 877,734 | 2.29B |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 10.68B | -0.14% | 546,128 | 4.16B |
| 20 | RNA | Avidity Biosciences, Inc. | 10.65B | -0.31% | 1,431,240 | 20.87M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.22B | 1.20% | 861,258 | 3.09B |
| 22 | TECH | Bio-Techne Corporation | 9.17B | 1.80% | 668,200 | 1.22B |
| 23 | MRNA | Moderna, Inc. | 9.07B | -4.01% | 9,165,896 | 2.23B |
| 24 | ABVX | ABIVAX Société Anonyme | 8.44B | 7.57% | 3,039,349 | 7.07M |
| 25 | HALO | Halozyme Therapeutics, Inc. | 8.15B | -1.31% | 350,123 | 1.24B |
| 26 | NUVL | Nuvalent, Inc. | 7.90B | 1.39% | 397,584 | - |
| 27 | CORT | Corcept Therapeutics Incorporated | 7.88B | -1.52% | 168,726 | 741.17M |
| 28 | CYTK | Cytokinetics, Incorporated | 7.69B | -2.93% | 694,763 | 87.21M |
| 29 | AXSM | Axsome Therapeutics, Inc. | 7.27B | -1.70% | 276,807 | 561.26M |
| 30 | MRUS | Merus N.V. | 7.27B | -0.17% | 1,376,581 | 56.61M |
| 31 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.95B | 0.92% | 265,954 | 174.33M |
| 32 | CDTX | Cidara Therapeutics, Inc. | 6.90B | 0.27% | 1,478,440 | 302.00K |
| 33 | CAI | Caris Life Sciences, Inc. | 6.79B | 0.63% | 1,041,717 | 649.06M |
| 34 | PCVX | Vaxcyte, Inc. | 6.21B | -2.41% | 443,429 | - |
| 35 | PTCT | PTC Therapeutics, Inc. | 6.14B | 1.18% | 648,093 | 1.78B |
| 36 | KRYS | Krystal Biotech, Inc. | 5.97B | 0.87% | 62,368 | 373.16M |
| 37 | COGT | Cogent Biosciences, Inc. | 5.35B | 0.60% | 2,598,570 | - |
| 38 | PTGX | Protagonist Therapeutics, Inc. | 5.31B | -0.27% | 407,404 | 209.22M |
| 39 | ARWR | Arrowhead Pharmaceuticals, Inc. | 5.29B | -1.82% | 1,317,781 | 572.98M |
| 40 | LEGN | Legend Biotech Corporation | 5.18B | 0.11% | 1,798,820 | 909.05M |
| 41 | ACLX | Arcellx, Inc. | 5.18B | -0.13% | 516,067 | 35.90M |
| 42 | CRSP | CRISPR Therapeutics AG | 4.72B | -2.40% | 1,081,054 | 38.34M |
| 43 | KYMR | Kymera Therapeutics, Inc. | 4.62B | -0.88% | 273,793 | 43.74M |
| 44 | AKRO | Akero Therapeutics, Inc. | 4.47B | 0.02% | 494,015 | - |
| 45 | TGTX | TG Therapeutics, Inc. | 4.46B | 0.66% | 1,158,964 | 531.90M |
| 46 | CELC | Celcuity Inc. | 4.41B | 1.14% | 374,032 | - |
| 47 | NAMS | NewAmsterdam Pharma Company N.V. | 4.38B | 0.08% | 638,114 | 35.24M |
| 48 | APGE | Apogee Therapeutics, Inc. | 4.33B | 0.41% | 321,766 | - |
| 49 | PRAX | Praxis Precision Medicines, Inc. | 4.28B | -9.68% | 1,232,302 | 7.46M |
| 50 | CNTA | Centessa Pharmaceuticals plc | 4.06B | -0.64% | 722,294 | 15.00M |
| 51 | IMVT | Immunovant, Inc. | 4.03B | -0.65% | 399,542 | - |
| 52 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.03B | -0.96% | 270,442 | 1.54M |
| 53 | VKTX | Viking Therapeutics, Inc. | 3.98B | -2.25% | 1,830,604 | - |
| 54 | SRRK | Scholar Rock Holding Corporation | 3.97B | -1.84% | 964,159 | - |
| 55 | ADMA | ADMA Biologics, Inc. | 3.88B | 2.32% | 1,968,104 | 488.56M |
| 56 | BLTE | Belite Bio, Inc | 3.88B | -7.72% | 59,240 | - |
| 57 | ACAD | ACADIA Pharmaceuticals Inc. | 3.87B | -0.89% | 410,124 | 1.05B |
| 58 | MIRM | Mirum Pharmaceuticals, Inc. | 3.62B | -0.11% | 174,316 | 471.79M |
| 59 | IRON | Disc Medicine, Inc. | 3.44B | 0.29% | 209,476 | - |
| 60 | ARQT | Arcutis Biotherapeutics, Inc. | 3.39B | -0.90% | 1,385,206 | 317.93M |
| 61 | CGON | CG Oncology, Inc. | 3.37B | -1.95% | 253,682 | 2.17M |
| 62 | MLYS | Mineralys Therapeutics, Inc. | 3.34B | 0.07% | 831,365 | - |
| 63 | TARS | Tarsus Pharmaceuticals, Inc. | 3.31B | 1.00% | 184,581 | 366.10M |
| 64 | TVTX | Travere Therapeutics, Inc. | 3.18B | 0.23% | 450,108 | 435.83M |
| 65 | XENE | Xenon Pharmaceuticals Inc. | 3.18B | 1.08% | 418,091 | 7.50M |
| 66 | RARE | Ultragenyx Pharmaceutical Inc. | 3.04B | -0.99% | 342,244 | 630.60M |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.04B | -2.32% | 56,215 | 664.23M |
| 68 | AAPG | Ascentage Pharma Group International | 3.02B | -0.47% | 1,440 | 54.52M |
| 69 | FOLD | Amicus Therapeutics, Inc. | 2.94B | -1.95% | 1,357,750 | 598.70M |
| 70 | IDYA | IDEAYA Biosciences, Inc. | 2.90B | -0.18% | 481,834 | 214.83M |
| 71 | DYN | Dyne Therapeutics, Inc. | 2.90B | -1.50% | 1,011,906 | - |
| 72 | VRDN | Viridian Therapeutics, Inc. | 2.79B | 2.09% | 1,119,527 | 70.79M |
| 73 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.77B | 0.13% | 320,775 | 578.20M |
| 74 | OCUL | Ocular Therapeutix, Inc. | 2.53B | -1.74% | 1,193,593 | 55.78M |
| 75 | LQDA | Liquidia Corporation | 2.53B | -1.80% | 1,183,895 | 69.22M |
| 76 | APLS | Apellis Pharmaceuticals, Inc. | 2.48B | 0.77% | 791,389 | 1.02B |
| 77 | DNLI | Denali Therapeutics Inc. | 2.48B | -0.08% | 525,142 | - |
| 78 | ADPT | Adaptive Biotechnologies Corporation | 2.47B | 6.73% | 1,951,558 | 252.75M |
| 79 | NUVB | Nuvation Bio Inc. | 2.45B | 48.96% | 59,110,306 | 26.75M |
| 80 | SLNO | Soleno Therapeutics, Inc. | 2.45B | -2.91% | 755,550 | 98.68M |
| 81 | EWTX | Edgewise Therapeutics, Inc. | 2.39B | 0.98% | 332,236 | - |
| 82 | TERN | Terns Pharmaceuticals, Inc. | 2.36B | -3.50% | 1,807,280 | - |
| 83 | RCUS | Arcus Biosciences, Inc. | 2.25B | 2.87% | 953,832 | 240.00M |
| 84 | ZLAB | Zai Lab Limited | 2.23B | -1.51% | 400,933 | 441.63M |
| 85 | GPCR | Structure Therapeutics Inc. | 2.13B | -4.01% | 822,967 | - |
| 86 | RXRX | Recursion Pharmaceuticals, Inc. | 2.07B | -1.24% | 20,844,236 | 43.69M |
| 87 | BEAM | Beam Therapeutics Inc. | 2.04B | -1.38% | 667,252 | 55.70M |
| 88 | IBRX | ImmunityBio, Inc. | 2.02B | -4.21% | 6,489,571 | 82.56M |
| 89 | GLPG | Galapagos NV | 2.01B | -1.18% | 58,346 | 336.64M |
| 90 | AUPH | Aurinia Pharmaceuticals Inc. | 2.01B | 0.33% | 625,225 | 265.81M |
| 91 | IMCR | Immunocore Holdings plc | 1.98B | 1.22% | 482,191 | 379.59M |
| 92 | ZBIO | Zenas BioPharma, Inc. | 1.94B | -2.58% | 223,384 | 15.00M |
| 93 | VCEL | Vericel Corporation | 1.93B | -1.85% | 125,761 | 258.72M |
| 94 | HRMY | Harmony Biosciences Holdings, Inc. | 1.91B | -0.60% | 271,387 | 825.94M |
| 95 | MESO | Mesoblast Limited | 1.91B | -1.41% | 56,200 | 17.20M |
| 96 | SYRE | Spyre Therapeutics, Inc. | 1.86B | -1.30% | 452,768 | - |
| 97 | VERA | Vera Therapeutics, Inc. | 1.80B | -1.40% | 490,406 | - |
| 98 | SRPT | Sarepta Therapeutics, Inc. | 1.78B | 3.60% | 2,508,065 | 2.41B |
| 99 | DNTH | Dianthus Therapeutics, Inc. | 1.78B | 1.54% | 461,686 | 3.08M |
| 100 | ZYME | Zymeworks Inc. | 1.76B | 4.20% | 683,830 | 134.48M |
| 101 | QURE | uniQure N.V. | 1.75B | 0.25% | 1,269,863 | 15.75M |
| 102 | MAZE | Maze Therapeutics, Inc. | 1.71B | 0.23% | 208,524 | 2.50M |
| 103 | SION | Sionna Therapeutics, Inc. | 1.71B | -0.05% | 89,837 | - |
| 104 | JANX | Janux Therapeutics, Inc. | 1.70B | -1.74% | 409,235 | 10.00M |
| 105 | CLDX | Celldex Therapeutics, Inc. | 1.65B | -0.08% | 229,757 | 2.60M |
| 106 | IMNM | Immunome, Inc. | 1.62B | -0.34% | 450,399 | 9.68M |
| 107 | PHVS | Pharvaris N.V. | 1.60B | 0.61% | 288,422 | - |
| 108 | STOK | Stoke Therapeutics, Inc. | 1.60B | -1.44% | 289,027 | 205.63M |
| 109 | INVA | Innoviva, Inc. | 1.59B | 0.14% | 247,211 | 388.52M |
| 110 | OLMA | Olema Pharmaceuticals, Inc. | 1.55B | 16.11% | 8,543,272 | - |
| 111 | MNKD | MannKind Corporation | 1.54B | 0.40% | 906,072 | 313.79M |
| 112 | NRIX | Nurix Therapeutics, Inc. | 1.54B | 5.86% | 1,255,957 | 83.69M |
| 113 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.53B | -2.72% | 529,237 | -665.00K |
| 114 | SNDX | Syndax Pharmaceuticals, Inc. | 1.52B | 4.37% | 1,654,172 | 111.30M |
| 115 | PGEN | Precigen, Inc. | 1.45B | -2.84% | 2,019,721 | 6.31M |
| 116 | AGIO | Agios Pharmaceuticals, Inc. | 1.43B | 9.62% | 5,611,356 | 44.79M |
| 117 | TRVI | Trevi Therapeutics, Inc. | 1.38B | -2.45% | 590,246 | - |
| 118 | UPB | Upstream Bio, Inc. | 1.36B | 0.64% | 177,073 | 2.80M |
| 119 | ARDX | Ardelyx, Inc. | 1.36B | 0.18% | 1,079,982 | 398.23M |
| 120 | ORKA | Oruka Therapeutics, Inc. | 1.35B | -1.17% | 223,855 | - |
| 121 | RAPP | Rapport Therapeutics, Inc. | 1.32B | 2.94% | 246,991 | - |
| 122 | BHVN | Biohaven Ltd. | 1.31B | 4.23% | 2,792,226 | - |
| 123 | ELVN | Enliven Therapeutics, Inc. | 1.30B | -0.86% | 160,051 | - |
| 124 | IMTX | Immatics N.V. | 1.24B | -1.45% | 224,176 | 99.45M |
| 125 | MBX | MBX Biosciences, Inc. | 1.23B | -0.37% | 358,761 | - |
| 126 | URGN | UroGen Pharma Ltd. | 1.20B | 1.42% | 304,581 | 96.52M |
| 127 | SVRA | Savara Inc. | 1.18B | 6.09% | 1,308,150 | - |
| 128 | INBX | Inhibrx Biosciences, Inc. | 1.17B | -1.81% | 173,807 | 1.40M |
| 129 | CVAC | CureVac N.V. | 1.17B | -0.29% | 320,352 | 599.54M |
| 130 | TNGX | Tango Therapeutics, Inc. | 1.17B | 4.77% | 1,471,026 | 66.50M |
| 131 | XERS | Xeris Biopharma Holdings, Inc. | 1.15B | -1.83% | 864,596 | 266.14M |
| 132 | NKTR | Nektar Therapeutics | 1.15B | -6.38% | 396,381 | 62.60M |
| 133 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.13B | -4.20% | 645,363 | 42.34M |
| 134 | ORIC | ORIC Pharmaceuticals, Inc. | 1.13B | 0.78% | 881,654 | - |
| 135 | XNCR | Xencor, Inc. | 1.12B | -0.19% | 238,454 | 150.13M |
| 136 | OCS | Oculis Holding AG | 1.12B | 0.34% | 49,869 | 992.00K |
| 137 | WVE | Wave Life Sciences Ltd. | 1.12B | -3.05% | 1,218,581 | 109.23M |
| 138 | RLAY | Relay Therapeutics, Inc. | 1.11B | 1.26% | 872,503 | 8.36M |
| 139 | MNMD | Mind Medicine (MindMed) Inc. | 1.11B | 3.02% | 843,288 | - |
| 140 | PHAR | Pharming Group N.V. | 1.10B | 0.01% | 12,487 | 362.27M |
| 141 | TSHA | Taysha Gene Therapies, Inc. | 1.09B | -1.00% | 1,354,540 | 6.31M |
| 142 | PVLA | Palvella Therapeutics, Inc. | 1.08B | -5.50% | 191,584 | - |
| 143 | SEPN | Septerna, Inc. | 1.06B | 2.60% | 108,880 | 22.05M |
| 144 | KOD | Kodiak Sciences Inc. | 1.06B | 2.25% | 382,854 | - |
| 145 | ABCL | AbCellera Biologics Inc. | 1.04B | -3.32% | 2,134,875 | 35.33M |
| 146 | ANAB | AnaptysBio, Inc. | 1.03B | 0.86% | 283,744 | 169.47M |
| 147 | NBTX | Nanobiotix S.A. | 1.03B | -4.76% | 28,442 | 11.93M |
| 148 | NVAX | Novavax, Inc. | 1.02B | -1.18% | 2,075,831 | 1.06B |
| 149 | PHAT | Phathom Pharmaceuticals, Inc. | 999.45M | -2.97% | 170,204 | 147.19M |
| 150 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 995.26M | -1.87% | 35,784 | - |
| 151 | TYRA | Tyra Biosciences, Inc. | 992.19M | 11.85% | 349,857 | - |
| 152 | KURA | Kura Oncology, Inc. | 983.30M | -0.18% | 926,738 | 104.03M |
| 153 | MDXG | MiMedx Group, Inc. | 973.03M | 1.39% | 401,105 | 393.44M |
| 154 | MLTX | MoonLake Immunotherapeutics | 959.26M | -0.74% | 738,072 | - |
| 155 | NTLA | Intellia Therapeutics, Inc. | 946.33M | -0.85% | 3,200,784 | 57.53M |
| 156 | FTRE | Fortrea Holdings Inc. | 927.70M | - | 297,485 | 2.76B |
| 157 | RZLT | Rezolute, Inc. | 916.15M | -2.76% | 426,647 | - |
| 158 | MRVI | Maravai LifeSciences Holdings, Inc. | 903.92M | 1.00% | 384,292 | 192.44M |
| 159 | TBPH | Theravance Biopharma, Inc. | 901.97M | 0.39% | 170,952 | 80.33M |
| 160 | GLUE | Monte Rosa Therapeutics, Inc. | 890.81M | -3.25% | 304,012 | 181.54M |
| 161 | IOVA | Iovance Biotherapeutics, Inc. | 877.30M | -2.21% | 4,400,590 | 250.43M |
| 162 | BCAX | Bicara Therapeutics Inc. | 874.32M | 5.14% | 446,190 | - |
| 163 | LENZ | LENZ Therapeutics, Inc. | 873.30M | -1.73% | 508,026 | 17.50M |
| 164 | GHRS | GH Research PLC | 873.06M | -2.12% | 108,655 | - |
| 165 | SANA | Sana Biotechnology, Inc. | 865.69M | -4.41% | 2,401,734 | - |
| 166 | CMPX | Compass Therapeutics, Inc. | 858.18M | -1.53% | 500,456 | 850.00K |
| 167 | DAWN | Day One Biopharmaceuticals, Inc. | 856.83M | -0.77% | 941,529 | 133.67M |
| 168 | AVBP | ArriVent BioPharma, Inc. | 830.99M | 0.50% | 81,552 | - |
| 169 | ABUS | Arbutus Biopharma Corporation | 809.68M | -1.41% | 555,737 | 14.61M |
| 170 | ATAI | Atai Beckley N.V. | 801.63M | -2.09% | 2,866,165 | 3.02M |
| 171 | RIGL | Rigel Pharmaceuticals, Inc. | 798.66M | 5.57% | 337,496 | 282.08M |
| 172 | ERAS | Erasca, Inc. | 795.81M | 1.63% | 970,969 | - |
| 173 | VIR | Vir Biotechnology, Inc. | 775.62M | 2.48% | 684,734 | 16.86M |
| 174 | RAPT | RAPT Therapeutics, Inc. | 760.94M | -3.04% | 105,049 | - |
| 175 | CRMD | CorMedix Inc. | 760.31M | -3.79% | 1,569,911 | 214.30M |
| 176 | VALN | Valneva SE | 740.18M | - | 15,835 | 211.09M |
| 177 | VSTM | Verastem, Inc. | 734.00M | 2.59% | 1,389,306 | 13.38M |
| 178 | ALMS | Alumis Inc. | 733.89M | 7.00% | 972,052 | 22.12M |
| 179 | GOSS | Gossamer Bio, Inc. | 717.51M | -1.27% | 1,624,204 | 44.05M |
| 180 | ARVN | Arvinas, Inc. | 714.82M | -3.47% | 1,138,198 | 312.30M |
| 181 | ATXS | Astria Therapeutics, Inc. | 710.71M | 0.08% | 251,267 | 706.00K |
| 182 | REPL | Replimune Group, Inc. | 702.07M | -0.44% | 594,005 | - |
| 183 | GERN | Geron Corporation | 689.42M | - | 4,651,812 | 183.40M |
| 184 | GYRE | Gyre Therapeutics, Inc. | 683.50M | -0.66% | 16,017 | 107.27M |
| 185 | SPRY | ARS Pharmaceuticals, Inc. | 682.06M | -2.68% | 855,480 | 142.77M |
| 186 | KALV | KalVista Pharmaceuticals, Inc. | 680.35M | -1.82% | 503,650 | 1.43M |
| 187 | VTYX | Ventyx Biosciences, Inc. | 673.63M | -0.32% | 1,079,613 | - |
| 188 | PROK | ProKidney Corp. | 670.86M | -3.88% | 551,518 | 744.00K |
| 189 | LXEO | Lexeo Therapeutics, Inc. | 667.10M | 0.55% | 796,351 | - |
| 190 | PRME | Prime Medicine, Inc. | 655.04M | -0.54% | 2,376,262 | 5.98M |
| 191 | CRVS | Corvus Pharmaceuticals, Inc. | 646.75M | -2.70% | 343,401 | - |
| 192 | ANNX | Annexon, Inc. | 641.15M | 9.11% | 5,746,795 | - |
| 193 | CTMX | CytomX Therapeutics, Inc. | 634.62M | 3.18% | 987,240 | 113.63M |
| 194 | YDES | YD Bio Limited | 615.30M | -5.91% | 53,678 | 510.36K |
| 195 | FDMT | 4D Molecular Therapeutics, Inc. | 614.20M | -0.46% | 543,819 | 120.00K |
| 196 | FULC | Fulcrum Therapeutics, Inc. | 604.50M | -2.95% | 421,489 | 80.00M |
| 197 | MGTX | MeiraGTx Holdings plc | 600.46M | -1.58% | 245,305 | 27.42M |
| 198 | ASMB | Assembly Biosciences, Inc. | 599.07M | -0.33% | 90,474 | 37.19M |
| 199 | MPLT | MapLight Therapeutics, Inc. | 590.47M | -7.33% | 60,262 | - |
| 200 | OMER | Omeros Corporation | 584.22M | 0.24% | 483,270 | - |
| 201 | IVVD | Invivyd, Inc. | 568.82M | -2.40% | 2,361,291 | 50.04M |
| 202 | EVMN | Evommune, Inc. | 568.17M | -2.07% | 24,715 | 3.00M |
| 203 | MNPR | Monopar Therapeutics Inc. | 556.66M | 0.36% | 51,217 | - |
| 204 | IVA | Inventiva S.A. | 555.45M | -2.18% | 41,497 | 19.93M |
| 205 | RGNX | REGENXBIO Inc. | 550.27M | -0.55% | 188,391 | 161.32M |
| 206 | JBIO | Jade Biosciences, Inc. | 547.45M | -4.49% | 55,775 | - |
| 207 | NAGE | Niagen Bioscience, Inc. | 546.21M | -1.16% | 281,539 | 124.71M |
| 208 | PRTA | Prothena Corporation plc | 539.38M | 0.30% | 122,774 | 11.79M |
| 209 | KROS | Keros Therapeutics, Inc. | 530.11M | 3.20% | 493,578 | 246.72M |
| 210 | ZVRA | Zevra Therapeutics, Inc. | 515.12M | -5.48% | 475,585 | 84.39M |
| 211 | CGEM | Cullinan Therapeutics, Inc. | 514.55M | 3.08% | 546,407 | - |
| 212 | NBP | NovaBridge Biosciences | 503.71M | -3.53% | 255,424 | - |
| 213 | ADCT | ADC Therapeutics SA | 499.22M | 0.25% | 322,150 | 75.21M |
| 214 | LXRX | Lexicon Pharmaceuticals, Inc. | 494.22M | -6.21% | 1,620,978 | 70.86M |
| 215 | DBVT | DBV Technologies S.A. | 485.34M | -6.78% | 42,626 | 5.50M |
| 216 | ANRO | Alto Neuroscience, Inc. | 468.48M | -2.96% | 232,238 | - |
| 217 | ALT | Altimmune, Inc. | 465.37M | -2.83% | 1,700,189 | 20.00K |
| 218 | DSGN | Design Therapeutics, Inc. | 455.71M | 8.99% | 341,416 | - |
| 219 | DRUG | Bright Minds Biosciences Inc. | 454.54M | -1.06% | 33,829 | - |
| 220 | IMRX | Immuneering Corporation | 451.99M | -2.37% | 526,795 | - |
| 221 | DNA | Ginkgo Bioworks Holdings, Inc. | 445.03M | -1.01% | 521,733 | 180.61M |
| 222 | BNTC | Benitec Biopharma Inc. | 443.60M | - | 59,582 | - |
| 223 | ABSI | Absci Corporation | 434.57M | 1.05% | 3,508,369 | 2.82M |
| 224 | BCYC | Bicycle Therapeutics plc | 425.57M | -1.84% | 227,415 | 28.34M |
| 225 | ENGN | enGene Holdings Inc. | 422.66M | -3.18% | 268,843 | - |
| 226 | LBRX | LB Pharmaceuticals Inc | 412.38M | 2.68% | 23,532 | - |
| 227 | NMRA | Neumora Therapeutics, Inc. | 409.37M | -3.54% | 662,076 | - |
| 228 | LCTX | Lineage Cell Therapeutics, Inc. | 408.32M | -1.46% | 1,205,836 | 10.82M |
| 229 | VTVT | vTv Therapeutics Inc. | 402.05M | 0.50% | 585 | 17.00K |
| 230 | XOMA | XOMA Royalty Corporation | 401.46M | -2.20% | 39,096 | 47.11M |
| 231 | PRTC | PureTech Health plc | 387.27M | 0.28% | 2,609 | 6.39M |
| 232 | DMAC | DiaMedica Therapeutics Inc. | 379.64M | -0.14% | 318,174 | - |
| 233 | GALT | Galectin Therapeutics Inc. | 377.49M | 2.00% | 124,558 | - |
| 234 | LYEL | Lyell Immunopharma, Inc. | 371.64M | 1.71% | 12,689 | 41.00K |
| 235 | PEPG | PepGen Inc. | 369.18M | -2.89% | 358,180 | - |
| 236 | FBRX | Forte Biosciences, Inc. | 363.07M | 8.87% | 168,930 | - |
| 237 | TECX | Tectonic Therapeutic, Inc. | 354.67M | 1.01% | 241,350 | - |
| 238 | OCGN | Ocugen, Inc. | 352.92M | -0.88% | 1,656,372 | 5.37M |
| 239 | CTNM | Contineum Therapeutics, Inc. | 352.09M | -2.94% | 52,496 | - |
| 240 | SLDB | Solid Biosciences Inc. | 349.04M | - | 437,141 | - |
| 241 | AURA | Aura Biosciences, Inc. | 344.82M | 0.56% | 82,479 | - |
| 242 | ENTA | Enanta Pharmaceuticals, Inc. | 340.67M | 0.74% | 87,496 | 65.32M |
| 243 | PALI | Palisade Bio, Inc. | 338.24M | 4.61% | 3,663,975 | - |
| 244 | KYTX | Kyverna Therapeutics, Inc. | 337.23M | -6.44% | 398,811 | - |
| 245 | AUTL | Autolus Therapeutics plc | 330.02M | -2.36% | 1,003,556 | 51.13M |
| 246 | CLLS | Cellectis S.A. | 325.83M | 8.18% | 285,502 | 82.55M |
| 247 | TRDA | Entrada Therapeutics, Inc. | 324.91M | 3.78% | 101,660 | 61.52M |
| 248 | XFOR | X4 Pharmaceuticals, Inc. | 317.40M | -0.55% | 271,877 | 33.98M |
| 249 | EPRX | Eupraxia Pharmaceuticals Inc. | 316.96M | 1.94% | 23,749 | - |
| 250 | RLMD | Relmada Therapeutics, Inc. | 316.07M | 3.11% | 649,312 | - |
| 251 | RCKT | Rocket Pharmaceuticals, Inc. | 313.84M | 0.69% | 1,468,399 | - |
| 252 | NGNE | Neurogene Inc. | 309.95M | -4.67% | 149,152 | 925.00K |
| 253 | AVTX | Avalo Therapeutics, Inc. | 308.28M | -3.35% | 100,452 | 192.00K |
| 254 | TENX | Tenax Therapeutics, Inc. | 305.49M | 2.87% | 25,196 | - |
| 255 | DRTS | Alpha Tau Medical Ltd. | 303.60M | -2.99% | 44,220 | - |
| 256 | ACIU | AC Immune SA | 296.83M | -3.85% | 73,208 | 5.48M |
| 257 | VNDA | Vanda Pharmaceuticals Inc. | 294.89M | -2.92% | 580,472 | 212.07M |
| 258 | CYBN | Cybin Inc. | 292.93M | -1.01% | 286,540 | - |
| 259 | SLN | Silence Therapeutics plc | 291.91M | -3.89% | 161,295 | 25.83M |
| 260 | PYXS | Pyxis Oncology, Inc. | 290.15M | 1.97% | 568,492 | 2.82M |
| 261 | LRMR | Larimar Therapeutics, Inc. | 288.44M | -2.88% | 583,710 | - |
| 262 | ALDX | Aldeyra Therapeutics, Inc. | 288.18M | -1.44% | 224,740 | - |
| 263 | AVXL | Anavex Life Sciences Corp. | 286.89M | -7.22% | 2,420,226 | - |
| 264 | MREO | Mereo BioPharma Group plc | 284.85M | -1.10% | 634,136 | 500.00K |
| 265 | ALLO | Allogene Therapeutics, Inc. | 282.04M | -0.40% | 1,593,302 | 22.00K |
| 266 | NAUT | Nautilus Biotechnology, Inc. | 276.61M | -9.13% | 409,402 | - |
| 267 | TARA | Protara Therapeutics, Inc. | 269.34M | 4.02% | 550,624 | - |
| 268 | FENC | Fennec Pharmaceuticals Inc. | 269.30M | -3.61% | 48,712 | 38.79M |
| 269 | CAPR | Capricor Therapeutics, Inc. | 263.80M | - | 518,385 | 11.13M |
| 270 | FHTX | Foghorn Therapeutics Inc. | 263.53M | -4.12% | 84,259 | 24.52M |
| 271 | ACRS | Aclaris Therapeutics, Inc. | 259.49M | -2.64% | 288,749 | 15.74M |
| 272 | IMMP | Immutep Limited | 252.06M | - | 33,593 | 3.31M |
| 273 | OBIO | Orchestra BioMed Holdings, Inc. | 251.83M | -4.29% | 234,146 | 2.82M |
| 274 | CBIO | Crescent Biopharma, Inc. | 251.80M | -1.15% | 39,940 | - |
| 275 | SGMT | Sagimet Biosciences Inc. | 247.16M | -3.18% | 126,159 | - |
| 276 | EDIT | Editas Medicine, Inc. | 244.05M | -0.79% | 885,998 | 46.38M |
| 277 | OABI | OmniAb, Inc. | 243.28M | 2.42% | 203,899 | 21.09M |
| 278 | CADL | Candel Therapeutics, Inc. | 243.20M | 0.23% | 433,420 | - |
| 279 | ARMP | Armata Pharmaceuticals, Inc. | 243.05M | -8.36% | 25,409 | 5.05M |
| 280 | PBYI | Puma Biotechnology, Inc. | 242.38M | -1.54% | 118,012 | 212.00M |
| 281 | ZURA | Zura Bio Limited | 241.24M | -4.13% | 167,837 | - |
| 282 | MIST | Milestone Pharmaceuticals Inc. | 237.19M | 0.21% | 2,662,174 | - |
| 283 | AVIR | Atea Pharmaceuticals, Inc. | 236.72M | -3.81% | 452,448 | - |
| 284 | VYGR | Voyager Therapeutics, Inc. | 231.30M | - | 209,405 | 31.32M |
| 285 | CCCC | C4 Therapeutics, Inc. | 230.66M | -4.80% | 825,228 | 30.11M |
| 286 | ABEO | Abeona Therapeutics Inc. | 229.23M | 0.71% | 1,043,008 | 400.00K |
| 287 | MDWD | MediWound Ltd. | 223.48M | -2.41% | 109,799 | 20.93M |
| 288 | AARD | Aardvark Therapeutics, Inc. | 221.00M | -2.96% | 39,482 | - |
| 289 | HUMA | Humacyte, Inc. | 219.11M | - | 3,218,067 | 1.57M |
| 290 | PRQR | ProQR Therapeutics N.V. | 218.06M | 1.97% | 362,231 | 18.86M |
| 291 | SLS | SELLAS Life Sciences Group, Inc. | 216.51M | - | 1,383,856 | - |
| 292 | BDTX | Black Diamond Therapeutics, Inc. | 213.94M | -3.47% | 522,049 | 70.00M |
| 293 | ACHV | Achieve Life Sciences, Inc. | 213.47M | -7.18% | 579,125 | - |
| 294 | CABA | Cabaletta Bio, Inc. | 206.49M | -4.24% | 2,031,917 | - |
| 295 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 205.28M | -1.06% | 168,468 | - |
| 296 | TNYA | Tenaya Therapeutics, Inc. | 196.48M | -0.84% | 1,446,076 | - |
| 297 | RANI | Rani Therapeutics Holdings, Inc. | 195.63M | -8.00% | 1,988,533 | 1.20M |
| 298 | HRTX | Heron Therapeutics, Inc. | 194.36M | -2.75% | 2,116,393 | 155.10M |
| 299 | TLSA | Tiziana Life Sciences Ltd | 192.49M | -4.14% | 79,546 | - |
| 300 | RNAC | Cartesian Therapeutics, Inc. | 190.09M | 2.24% | 56,776 | 1.09M |
| 301 | TNXP | Tonix Pharmaceuticals Holding Corp. | 188.31M | -4.37% | 655,318 | 10.30M |
| 302 | GNLX | Genelux Corporation | 180.00M | -4.30% | 152,427 | 8.00K |
| 303 | GUTS | Fractyl Health, Inc. | 176.79M | -3.01% | 675,629 | 3.00K |
| 304 | VTGN | Vistagen Therapeutics, Inc. | 174.57M | -1.78% | 1,321,763 | 721.00K |
| 305 | IPHA | Innate Pharma S.A. | 169.06M | 3.35% | 37,171 | 14.84M |
| 306 | ARCT | Arcturus Therapeutics Holdings Inc. | 167.92M | -2.15% | 488,028 | 97.60M |
| 307 | CAMP | Camp4 Therapeutics Corporation | 166.90M | -4.04% | 35,493 | 3.80M |
| 308 | CNTB | Connect Biopharma Holdings Limited | 165.47M | -6.03% | 587,549 | 762.00K |
| 309 | ETHZ | ETHZilla Corporation | 163.43M | -6.77% | 572,598 | 4.11M |
| 310 | CRBU | Caribou Biosciences, Inc. | 162.63M | -4.40% | 996,173 | 9.30M |
| 311 | MOLN | Molecular Partners AG | 158.14M | -1.67% | 380 | 856.30K |
| 312 | MCRB | Seres Therapeutics, Inc. | 157.95M | -39.02% | 1,337,346 | 351.00K |
| 313 | NVCT | Nuvectis Pharma, Inc. | 152.66M | -0.17% | 29,758 | - |
| 314 | CGEN | Compugen Ltd. | 146.38M | -2.19% | 143,561 | 6.90M |
| 315 | CDXS | Codexis, Inc. | 146.33M | - | 321,336 | 52.93M |
| 316 | ANIX | Anixa Biosciences, Inc. | 143.26M | 0.05% | 169,900 | - |
| 317 | AGEN | Agenus Inc. | 142.49M | -0.24% | 200,812 | 106.83M |
| 318 | ELTX | Elicio Therapeutics, Inc. | 140.67M | -0.62% | 35,482 | - |
| 319 | VOR | Vor Biopharma Inc. | 139.40M | -12.66% | 644,617 | - |
| 320 | ACTU | Actuate Therapeutics, Inc. | 139.00M | 2.22% | 64,217 | - |
| 321 | MRSN | Mersana Therapeutics, Inc. | 137.74M | -0.04% | 68,238 | 33.18M |
| 322 | PLX | Protalix BioTherapeutics, Inc. | 137.52M | -3.39% | 276,489 | 61.84M |
| 323 | IMMX | Immix Biopharma, Inc. | 136.66M | -3.78% | 281,220 | - |
| 324 | CHRS | Coherus Oncology, Inc. | 135.38M | -3.45% | 500,239 | 277.73M |
| 325 | IRD | Opus Genetics, Inc. | 135.17M | 5.38% | 573,024 | 14.63M |
| 326 | CRDF | Cardiff Oncology, Inc. | 135.06M | 0.25% | 504,565 | 501.00K |
| 327 | EXOZ | eXoZymes, Inc. | 134.83M | -0.62% | 915 | -700.00 |
| 328 | ALEC | Alector, Inc. | 134.80M | 1.23% | 1,395,574 | 69.05M |
| 329 | SGMO | Sangamo Therapeutics, Inc. | 131.23M | -0.54% | 3,206,817 | 32.88M |
| 330 | PRLD | Prelude Therapeutics Incorporated | 129.36M | -5.99% | 152,775 | 10.50M |
| 331 | KLRS | Kalaris Therapeutics, Inc. | 129.05M | 3.29% | 112,166 | - |
| 332 | SAVA | Cassava Sciences, Inc. | 128.98M | -2.91% | 885,527 | - |
| 333 | SPRO | Spero Therapeutics, Inc. | 127.89M | -4.62% | 208,424 | 40.55M |
| 334 | NBY | NovaBay Pharmaceuticals, Inc. | 126.19M | 0.14% | 41,943 | 10.30M |
| 335 | ENTX | Entera Bio Ltd. | 124.66M | 3.02% | 77,441 | 124.00K |
| 336 | NKTX | Nkarta, Inc. | 124.30M | -2.23% | 295,003 | - |
| 337 | COYA | Coya Therapeutics, Inc. | 124.29M | 2.59% | 156,582 | 3.99M |
| 338 | ACOG | Alpha Cognition Inc. | 124.16M | 0.34% | 19,431 | 7.43M |
| 339 | CNTX | Context Therapeutics Inc. | 123.11M | -1.28% | 220,298 | - |
| 340 | INO | Inovio Pharmaceuticals, Inc. | 122.29M | - | 494,922 | 182.34K |
| 341 | NTHI | NeOnc Technologies Holdings, Inc. | 120.51M | -6.54% | 24,569 | 59.99K |
| 342 | STTK | Shattuck Labs, Inc. | 119.92M | -3.32% | 63,239 | 1.00M |
| 343 | CLYM | Climb Bio, Inc. | 119.32M | -4.89% | 303,394 | - |
| 344 | SRZN | Surrozen, Inc. | 118.46M | 2.37% | 54,576 | 3.60M |
| 345 | CGTX | Cognition Therapeutics, Inc. | 116.52M | -5.04% | 732,553 | - |
| 346 | GLSI | Greenwich LifeSciences, Inc. | 115.96M | 2.95% | 15,384 | - |
| 347 | IKT | Inhibikase Therapeutics, Inc. | 115.77M | -1.28% | 19,316 | 1.00 |
| 348 | FATE | Fate Therapeutics, Inc. | 115.35M | -4.76% | 728,642 | 7.14M |
| 349 | DTIL | Precision BioSciences, Inc. | 114.34M | -1.45% | 106,250 | 698.00K |
| 350 | UNCY | Unicycive Therapeutics, Inc. | 113.86M | -4.19% | 180,093 | - |
| 351 | SPRB | Spruce Biosciences, Inc. | 112.39M | -5.41% | 127,175 | 697.00K |
| 352 | QNCX | Quince Therapeutics, Inc. | 111.36M | 3.63% | 491,475 | - |
| 353 | SEER | Seer, Inc. | 108.51M | -2.75% | 81,175 | 16.38M |
| 354 | ELDN | Eledon Pharmaceuticals, Inc. | 108.21M | -7.10% | 1,672,121 | - |
| 355 | ONCY | Oncolytics Biotech Inc. | 106.15M | -3.85% | 501,588 | - |
| 356 | GANX | Gain Therapeutics, Inc. | 106.13M | 6.91% | 1,116,563 | - |
| 357 | ATRA | Atara Biotherapeutics, Inc. | 105.80M | 6.80% | 49,191 | 151.93M |
| 358 | ANVS | Annovis Bio, Inc. | 100.18M | 11.83% | 2,551,327 | - |
| 359 | VANI | Vivani Medical, Inc. | 99.94M | - | 163,894 | - |
| 360 | KPTI | Karyopharm Therapeutics Inc. | 99.41M | -2.51% | 59,200 | 142.53M |
| 361 | SLGL | Sol-Gel Technologies Ltd. | 98.39M | -2.00% | 19,939 | 18.97M |
| 362 | ATOS | Atossa Therapeutics, Inc. | 97.96M | -0.68% | 319,730 | - |
| 363 | ANEB | Anebulo Pharmaceuticals, Inc. | 96.78M | 2.41% | 1,178 | - |
| 364 | WHWK | Whitehawk Therapeutics, Inc. | 96.14M | -2.39% | 72,995 | 14.38M |
| 365 | ORMP | Oramed Pharmaceuticals Inc. | 95.92M | -3.41% | 97,084 | 2.00M |
| 366 | ACET | Adicet Bio, Inc. | 95.60M | 2.43% | 562,679 | - |
| 367 | PLRX | Pliant Therapeutics, Inc. | 94.02M | 2.00% | 788,708 | - |
| 368 | ABOS | Acumen Pharmaceuticals, Inc. | 93.89M | - | 112,071 | - |
| 369 | ZNTL | Zentalis Pharmaceuticals, Inc. | 92.84M | -3.38% | 314,676 | 26.87M |
| 370 | ADVM | Adverum Biotechnologies, Inc. | 92.61M | -1.29% | 179,274 | 1.00M |
| 371 | RPTX | Repare Therapeutics Inc. | 91.93M | -0.47% | 790,663 | 11.87M |
| 372 | CSBR | Champions Oncology, Inc. | 91.69M | -2.92% | 232 | 56.88M |
| 373 | VXRT | Vaxart, Inc. | 89.95M | -3.47% | 138,451 | 80.72M |
| 374 | OVID | Ovid Therapeutics Inc. | 88.30M | -3.13% | 742,310 | 6.61M |
| 375 | MGNX | MacroGenics, Inc. | 87.30M | -2.82% | 335,235 | 127.63M |
| 376 | COEP | Coeptis Therapeutics Holdings, Inc. | 87.10M | 2.19% | 32,578 | 501.00K |
| 377 | ADAG | Adagene Inc. | 86.72M | 1.66% | 18,428 | 103.20K |
| 378 | HURA | TuHURA Biosciences, Inc. | 86.11M | -4.00% | 169,681 | - |
| 379 | TVGN | Tevogen Bio Holdings Inc. | 86.07M | -3.60% | 212,651 | - |
| 380 | OTLK | Outlook Therapeutics, Inc. | 84.40M | -3.06% | 2,439,639 | 1.51M |
| 381 | CRVO | CervoMed Inc. | 83.64M | 4.93% | 76,341 | 6.16M |
| 382 | IMUX | Immunic, Inc. | 82.44M | -3.91% | 1,001,387 | - |
| 383 | PTHS | Pelthos Therapeutics Inc. | 82.16M | -10.58% | 16,437 | 7.41M |
| 384 | HYFT | MindWalk Holdings Corp. | 81.92M | -1.93% | 279,560 | 18.21M |
| 385 | TIL | Instil Bio, Inc. | 80.23M | -3.03% | 23,906 | - |
| 386 | ARTV | Artiva Biotherapeutics, Inc. | 79.53M | -4.42% | 52,979 | 251.00K |
| 387 | TTRX | Turn Therapeutics Inc. | 78.27M | -6.07% | 103,927 | - |
| 388 | IMA | ImageneBio, Inc. | 78.18M | 0.14% | 3,159 | 800.00K |
| 389 | IFRX | InflaRx N.V. | 77.91M | -8.73% | 886,123 | 73.73K |
| 390 | THAR | Tharimmune, Inc. | 77.80M | -10.84% | 299,729 | - |
| 391 | FBIO | Fortress Biotech, Inc. | 76.47M | -1.15% | 137,856 | 62.30M |
| 392 | ALXO | ALX Oncology Holdings Inc. | 76.45M | -4.08% | 109,757 | - |
| 393 | BMEA | Biomea Fusion, Inc. | 73.89M | -5.00% | 1,016,306 | - |
| 394 | BYSI | BeyondSpring Inc. | 73.40M | -6.67% | 17,741 | 1.88M |
| 395 | ACRV | Acrivon Therapeutics, Inc. | 72.98M | -1.69% | 540,541 | - |
| 396 | OKYO | OKYO Pharma Limited | 72.96M | -3.96% | 108,256 | - |
| 397 | PMVP | PMV Pharmaceuticals, Inc. | 71.57M | -1.10% | 40,821 | - |
| 398 | STRO | Sutro Biopharma, Inc. | 71.51M | -7.69% | 289,455 | 105.65M |
| 399 | CBUS | Cibus, Inc. | 69.75M | 1.18% | 102,112 | 3.79M |
| 400 | BCAB | BioAtla, Inc. | 69.67M | 2.16% | 1,273,501 | 11.00M |
| 401 | MNOV | MediciNova, Inc. | 69.65M | -0.70% | 16,464 | 257.92K |
| 402 | PSTV | Plus Therapeutics, Inc. | 68.08M | 1.08% | 22,303,096 | 5.26M |
| 403 | XBIT | XBiotech Inc. | 66.77M | 1.39% | 56,531 | - |
| 404 | ATYR | aTyr Pharma, Inc. | 64.89M | -1.93% | 2,271,334 | 190.00K |
| 405 | ABVC | ABVC BioPharma, Inc. | 64.35M | 0.37% | 25,602 | 797.92K |
| 406 | LITS | Lite Strategy, Inc. | 63.64M | -2.81% | 545,491 | - |
| 407 | ESLA | Estrella Immunopharma, Inc. | 63.45M | -4.00% | 155,914 | - |
| 408 | ATHE | Alterity Therapeutics Limited | 63.25M | -1.65% | 6,690 | 3.57M |
| 409 | NTRB | Nutriband Inc. | 62.96M | 1.75% | 6,568 | 2.58M |
| 410 | PYPD | PolyPid Ltd. | 60.88M | 1.67% | 63,634 | - |
| 411 | EQ | Equillium, Inc. | 60.75M | -1.22% | 640,811 | 4.39M |
| 412 | MGX | Metagenomi, Inc. | 58.20M | -3.73% | 259,187 | 30.91M |
| 413 | KRRO | Korro Bio, Inc. | 57.07M | -5.46% | 303,635 | 7.37M |
| 414 | TCRX | TScan Therapeutics, Inc. | 56.75M | -2.91% | 284,153 | 8.42M |
| 415 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 55.30M | -3.51% | 1,401,239 | - |
| 416 | OSTX | OS Therapies Incorporated | 54.99M | -0.61% | 144,068 | - |
| 417 | ALGS | Aligos Therapeutics, Inc. | 50.52M | -0.24% | 94,487 | 2.65M |
| 418 | JSPR | Jasper Therapeutics, Inc. | 50.37M | -2.70% | 254,134 | - |
| 419 | ANL | Adlai Nortye Ltd. | 50.18M | -6.85% | 6,553 | 1.94M |
| 420 | INKT | MiNK Therapeutics, Inc. | 49.64M | -0.41% | 27,390 | - |
| 421 | CVM | CEL-SCI Corporation | 49.16M | -1.13% | 32,111 | - |
| 422 | NRXP | NRx Pharmaceuticals, Inc. | 48.49M | -4.23% | 212,756 | 242.00K |
| 423 | IOBT | IO Biotech, Inc. | 48.42M | -2.21% | 205,083 | - |
| 424 | TELO | Telomir Pharmaceuticals, Inc. | 47.45M | -3.50% | 123,123 | - |
| 425 | IBO | Impact BioMedical Inc. | 47.09M | 2.51% | 16,092 | 25.00K |
| 426 | LVTX | LAVA Therapeutics N.V. | 46.82M | -1.66% | 196,974 | 4.99M |
| 427 | CALC | CalciMedica, Inc. | 46.11M | 1.39% | 8,400 | - |
| 428 | CUE | Cue Biopharma, Inc. | 46.06M | 0.83% | 89,860 | 7.10M |
| 429 | GRCE | Grace Therapeutics, Inc. | 45.35M | 2.88% | 91,757 | - |
| 430 | KZR | Kezar Life Sciences, Inc. | 45.33M | -0.16% | 13,383 | - |
| 431 | CELU | Celularity Inc. | 44.92M | -0.43% | 45,614 | 40.58M |
| 432 | EVAX | Evaxion A/S | 44.34M | 9.43% | 142,837 | 7.65M |
| 433 | SNTI | Senti Biosciences, Inc. | 44.30M | -4.26% | 13,601 | - |
| 434 | GNTA | Genenta Science S.p.A. | 43.82M | 5.65% | 71,422 | - |
| 435 | JUNS | Jupiter Neurosciences, Inc. | 43.54M | -3.85% | 32,142 | - |
| 436 | HOWL | Werewolf Therapeutics, Inc. | 42.96M | -4.29% | 352,772 | 1.14M |
| 437 | ICCC | ImmuCell Corporation | 41.79M | -2.53% | 4,742 | 27.77M |
| 438 | SKYE | Skye Bioscience, Inc. | 41.67M | -0.76% | 96,859 | - |
| 439 | IPSC | Century Therapeutics, Inc. | 41.64M | -7.74% | 338,728 | 113.34M |
| 440 | SER | Serina Therapeutics, Inc. | 41.48M | 0.67% | 958 | 116.00K |
| 441 | ATNM | Actinium Pharmaceuticals, Inc. | 41.33M | -2.57% | 105,286 | 90.00K |
| 442 | VRCA | Verrica Pharmaceuticals Inc. | 40.99M | -3.13% | 43,377 | 30.83M |
| 443 | PDSB | PDS Biotechnology Corporation | 40.63M | 2.67% | 392,559 | - |
| 444 | SABS | SAB Biotherapeutics, Inc. | 40.29M | 1.04% | 120,205 | 114.70K |
| 445 | BTAI | BioXcel Therapeutics, Inc. | 40.24M | 5.75% | 498,041 | 752.00K |
| 446 | INMB | INmune Bio, Inc. | 40.14M | - | 237,571 | 50.00K |
| 447 | APLT | Applied Therapeutics, Inc. | 40.12M | -2.46% | 7,235,752 | 1.00M |
| 448 | RADX | Radiopharm Theranostics Limited | 39.53M | 2.49% | 8,199 | 8.20M |
| 449 | XLO | Xilio Therapeutics, Inc. | 38.56M | -9.00% | 622,405 | 31.80M |
| 450 | TVRD | Tvardi Therapeutics, Inc. | 36.35M | -1.40% | 39,841 | - |
| 451 | MURA | Mural Oncology plc | 36.21M | 0.48% | 33,243 | - |
| 452 | OKUR | OnKure Therapeutics, Inc. | 36.17M | -3.26% | 31,234 | - |
| 453 | LTRN | Lantern Pharma Inc. | 35.90M | -1.84% | 28,142 | - |
| 454 | GBIO | Generation Bio Co. | 35.10M | 0.58% | 35,136 | 15.27M |
| 455 | VERU | Veru Inc. | 35.07M | -8.58% | 133,462 | 16.89M |
| 456 | DYAI | Dyadic International, Inc. | 34.41M | 2.45% | 98,849 | 3.34M |
| 457 | APLM | Apollomics, Inc. | 34.36M | -10.46% | 11,629 | 198.00K |
| 458 | FGEN | FibroGen, Inc. | 34.26M | -0.94% | 17,201 | 8.30M |
| 459 | LNAI | Lunai Bioworks Inc. | 33.84M | -2.67% | 931,641 | - |
| 460 | MAIA | MAIA Biotechnology, Inc. | 32.40M | -4.90% | 112,882 | - |
| 461 | NXTC | NextCure, Inc. | 31.44M | -0.85% | 16,556 | - |
| 462 | RNTX | Rein Therapeutics Inc. | 31.35M | 6.75% | 157,867 | - |
| 463 | PLUR | Pluri Inc. | 31.24M | 7.43% | 78,627 | 1.33M |
| 464 | HYPD | Hyperion DeFi, Inc. | 30.87M | -8.88% | 183,560 | 345.32K |
| 465 | KLTO | Klotho Neurosciences, Inc. | 30.29M | -8.09% | 599,844 | - |
| 466 | BRNS | Barinthus Biotherapeutics plc | 29.85M | 0.14% | 62,530 | 14.97M |
| 467 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 29.72M | -3.47% | 357,624 | 1.00M |
| 468 | ANTX | AN2 Therapeutics, Inc. | 29.59M | - | 20,294 | - |
| 469 | IGC | IGC Pharma, Inc. | 29.43M | -1.84% | 212,564 | 1.11M |
| 470 | NERV | Minerva Neurosciences, Inc. | 29.19M | -2.92% | 20,030 | - |
| 471 | LIMN | Liminatus Pharma, Inc. | 28.69M | -5.36% | 59,308 | - |
| 472 | RNXT | RenovoRx, Inc. | 27.71M | 3.21% | 152,272 | 928.00K |
| 473 | XCUR | Exicure, Inc. | 27.66M | -8.44% | 31,795 | 500.00K |
| 474 | NRXS | NeurAxis, Inc. | 27.38M | 1.18% | 45,232 | 3.36M |
| 475 | NRSN | NeuroSense Therapeutics Ltd. | 26.80M | -1.83% | 311,463 | - |
| 476 | RLYB | Rallybio Corporation | 26.00M | -1.41% | 272,437 | 674.00K |
| 477 | CLGN | CollPlant Biotechnologies Ltd. | 25.69M | -5.61% | 4,799 | 2.40M |
| 478 | LEXX | Lexaria Bioscience Corp. | 25.13M | 2.73% | 180,342 | 615.92K |
| 479 | BOLD | Boundless Bio, Inc. | 25.07M | -2.61% | 22,973 | - |
| 480 | QTTB | Q32 Bio Inc. | 25.04M | -4.01% | 57,550 | - |
| 481 | NNVC | NanoViricides, Inc. | 24.83M | -9.22% | 343,707 | - |
| 482 | CASI | CASI Pharmaceuticals, Inc. | 24.76M | 0.42% | 8,692 | 26.85M |
| 483 | LIXT | Lixte Biotechnology Holdings, Inc. | 24.70M | - | 7,627 | - |
| 484 | PASG | Passage Bio, Inc. | 24.32M | -2.92% | 17,916 | - |
| 485 | QNTM | Quantum BioPharma Ltd. | 23.91M | -2.06% | 35,396 | - |
| 486 | GLTO | Galecto, Inc. | 23.90M | -11.41% | 105,914 | - |
| 487 | DARE | Daré Bioscience, Inc. | 23.79M | -2.63% | 63,678 | -57.13K |
| 488 | CVKD | Cadrenal Therapeutics, Inc. | 23.62M | 1.06% | 4,286 | - |
| 489 | INTS | Intensity Therapeutics, Inc. | 23.59M | -8.10% | 1,805,141 | - |
| 490 | ENLV | Enlivex Therapeutics Ltd. | 22.85M | 0.21% | 106,956 | - |
| 491 | IBIO | iBio, Inc. | 22.82M | -6.88% | 708,295 | 500.00K |
| 492 | PTN | Palatin Technologies, Inc. | 22.39M | 1.87% | 22,446 | 8.85M |
| 493 | MBRX | Moleculin Biotech, Inc. | 22.15M | -0.73% | 611,574 | - |
| 494 | GDTC | CytoMed Therapeutics Limited | 22.04M | 5.52% | 13,383 | 573.19K |
| 495 | PMN | ProMIS Neurosciences, Inc. | 21.61M | -3.32% | 351,030 | - |
| 496 | SYBX | Synlogic, Inc. | 19.66M | 3.73% | 2,456 | 8.00K |
| 497 | CING | Cingulate Inc. | 19.62M | 2.34% | 36,101 | - |
| 498 | APVO | Aptevo Therapeutics Inc. | 18.54M | -9.84% | 587,704 | - |
| 499 | CTXR | Citius Pharmaceuticals, Inc. | 18.15M | -1.74% | 164,204 | - |
| 500 | LPCN | Lipocine Inc. | 18.10M | 1.56% | 13,278 | 4.32M |
| 501 | ATHA | Athira Pharma, Inc. | 17.89M | -4.73% | 23,762 | - |
| 502 | ITRM | Iterum Therapeutics plc | 17.71M | -4.26% | 1,016,415 | 390.00K |
| 503 | LSTA | Lisata Therapeutics, Inc. | 17.70M | -1.17% | 7,650 | 1.07M |
| 504 | PULM | Pulmatrix, Inc. | 17.64M | 10.27% | 3,356 | 3.00K |
| 505 | TRAW | Traws Pharma, Inc. | 17.58M | 4.27% | 331,761 | 2.85M |
| 506 | MTVA | MetaVia Inc. | 17.40M | -5.93% | 125,655 | - |
| 507 | AKTX | Akari Therapeutics, Plc | 17.30M | -2.95% | 44,641 | - |
| 508 | TPST | Tempest Therapeutics, Inc. | 17.09M | -18.95% | 354,968 | - |
| 509 | HOTH | Hoth Therapeutics, Inc. | 16.99M | -4.78% | 1,745,809 | - |
| 510 | MRKR | Marker Therapeutics, Inc. | 16.92M | -6.88% | 472,175 | 4.69M |
| 511 | FBLG | FibroBiologics, Inc. | 16.58M | -6.46% | 801,816 | - |
| 512 | ABP | Abpro Holdings, Inc. | 16.48M | 0.49% | 24,994 | 183.00K |
| 513 | CANF | Can-Fite BioPharma Ltd. | 15.62M | -6.28% | 3,891,588 | 560.00K |
| 514 | PCSA | Processa Pharmaceuticals, Inc. | 15.58M | -1.29% | 1,067,906 | - |
| 515 | NCEL | NewcelX Ltd. | 15.50M | 2.72% | 11,602 | - |
| 516 | ALLR | Allarity Therapeutics, Inc. | 15.11M | -2.80% | 134,578 | - |
| 517 | NCNA | NuCana plc | 15.07M | 8.06% | 116,187 | - |
| 518 | QNRX | Quoin Pharmaceuticals, Ltd. | 14.63M | -4.07% | 37,358 | - |
| 519 | CRIS | Curis, Inc. | 14.42M | -1.28% | 96,549 | 11.65M |
| 520 | BLRX | BioLineRx Ltd. | 14.33M | -1.80% | 20,386 | 17.25M |
| 521 | BCDA | BioCardia, Inc. | 14.33M | 2.27% | 37,777 | 3.00K |
| 522 | KAPA | Kairos Pharma, Ltd. | 14.31M | -3.36% | 104,572 | - |
| 523 | CLSD | Clearside Biomedical, Inc. | 14.13M | -5.59% | 24,389 | 3.33M |
| 524 | DWTX | Dogwood Therapeutics, Inc. | 13.90M | 1.51% | 16,404 | - |
| 525 | BCTX | BriaCell Therapeutics Corp. | 13.55M | -1.84% | 18,814 | - |
| 526 | KZIA | Kazia Therapeutics Limited | 13.22M | -6.91% | 455,140 | 1.20M |
| 527 | PHIO | Phio Pharmaceuticals Corp. | 13.08M | -2.80% | 266,383 | - |
| 528 | LGVN | Longeveron Inc. | 13.02M | -0.73% | 221,293 | 1.44M |
| 529 | SNGX | Soligenix, Inc. | 13.01M | -2.27% | 105,173 | 2.34K |
| 530 | CMMB | Chemomab Therapeutics Ltd. | 12.93M | -7.41% | 94,850 | - |
| 531 | COCP | Cocrystal Pharma, Inc. | 12.39M | -4.05% | 53,247 | - |
| 532 | OSRH | OSR Holdings, Inc. | 12.32M | -2.42% | 80,293 | -90.52K |
| 533 | GOVX | GeoVax Labs, Inc. | 12.16M | -1.30% | 760,201 | 3.35M |
| 534 | EDSA | Edesa Biotech, Inc. | 12.10M | -0.58% | 10,918 | - |
| 535 | APM | Aptorum Group Limited | 11.89M | -9.88% | 188,950 | - |
| 536 | CLRB | Cellectar Biosciences, Inc. | 11.79M | -2.80% | 21,765 | - |
| 537 | SNSE | Sensei Biotherapeutics, Inc. | 11.76M | -6.94% | 18,030 | - |
| 538 | VYNE | VYNE Therapeutics Inc. | 11.65M | -2.86% | 919,058 | 524.00K |
| 539 | IMNN | Imunon, Inc. | 11.39M | -1.85% | 18,214 | - |
| 540 | IMRN | Immuron Limited | 11.13M | 4.58% | 70,912 | 4.78M |
| 541 | ICU | SeaStar Medical Holding Corporation | 10.92M | -2.70% | 497,093 | 881.00K |
| 542 | PPCB | Propanc Biopharma, Inc. | 10.52M | -4.47% | 35,264 | - |
| 543 | ADXN | Addex Therapeutics Ltd | 10.45M | -10.27% | 12,793 | 210.35K |
| 544 | EVGN | Evogene Ltd. | 10.31M | -5.98% | 45,507 | 9.44M |
| 545 | ERNA | Ernexa Therapeutics Inc. | 10.28M | -5.76% | 45,544 | 1,000.00 |
| 546 | NEUP | Neuphoria Therapeutics Inc. | 10.28M | -1.38% | 17,674 | 15.65M |
| 547 | BIVI | BioVie Inc. | 10.25M | -0.73% | 39,281 | - |
| 548 | CELZ | Creative Medical Technology Holdings, Inc. | 10.09M | -6.19% | 98,729 | 6.00K |
| 549 | BRTX | BioRestorative Therapies, Inc. | 10.07M | -20.63% | 376,979 | 383.40K |
| 550 | CLDI | Calidi Biotherapeutics, Inc. | 10.03M | -4.86% | 64,997 | - |
| 551 | AEON | AEON Biopharma, Inc. | 9.20M | -15.99% | 321,567 | - |
| 552 | BOLT | Bolt Biotherapeutics, Inc. | 9.19M | 2.35% | 13,251 | 5.20M |
| 553 | MBIO | Mustang Bio, Inc. | 8.50M | -2.92% | 22,364 | - |
| 554 | ACXP | Acurx Pharmaceuticals, Inc. | 8.34M | - | 29,567 | - |
| 555 | XTLB | XTL Biopharmaceuticals Ltd. | 8.33M | -3.01% | 14,602 | 451.00K |
| 556 | ALZN | Alzamend Neuro, Inc. | 8.05M | -8.34% | 104,051 | - |
| 557 | PLRZ | Polyrizon Ltd. | 7.80M | -6.09% | 339,875 | - |
| 558 | TCRT | Alaunos Therapeutics, Inc. | 7.74M | 4.83% | 46,509 | 6.00K |
| 559 | INAB | IN8bio, Inc. | 7.55M | 0.62% | 36,564 | - |
| 560 | GTBP | GT Biopharma, Inc. | 7.25M | 0.19% | 805,247 | - |
| 561 | PHGE | BiomX Inc. | 7.23M | 1.53% | 524,174 | - |
| 562 | ADIL | Adial Pharmaceuticals, Inc. | 7.22M | -5.02% | 165,234 | - |
| 563 | RNAZ | TransCode Therapeutics, Inc. | 7.21M | -3.84% | 2,299 | - |
| 564 | APRE | Aprea Therapeutics, Inc. | 7.19M | -5.00% | 43,297 | 488.24K |
| 565 | TOVX | Theriva Biologics, Inc. | 7.17M | -7.77% | 2,879,866 | - |
| 566 | KPRX | Kiora Pharmaceuticals, Inc. | 6.93M | -1.56% | 15,034 | 20.00K |
| 567 | PPBT | Purple Biotech Ltd | 6.61M | -4.05% | 148,916 | - |
| 568 | LYRA | Lyra Therapeutics, Inc. | 5.86M | -4.90% | 14,626 | 600.00K |
| 569 | CYCN | Cyclerion Therapeutics, Inc. | 5.67M | 5.67% | 42,097 | 2.86M |
| 570 | VIVS | VivoSim Labs, Inc. | 5.63M | 0.93% | 24,760 | 140.00K |
| 571 | ENSC | Ensysce Biosciences, Inc. | 5.62M | -13.31% | 302,790 | 4.49M |
| 572 | MTNB | Matinas BioPharma Holdings, Inc. | 5.38M | 3.96% | 7,397 | - |
| 573 | GNPX | Genprex, Inc. | 5.27M | -2.99% | 105,194 | - |
| 574 | XBIO | Xenetic Biosciences, Inc. | 5.22M | -10.24% | 72,885 | 2.86M |
| 575 | PMCB | PharmaCyte Biotech, Inc. | 5.16M | 6.44% | 11,251 | - |
| 576 | REVB | Revelation Biosciences, Inc. | 5.08M | 0.48% | 142,525 | - |
| 577 | GRI | GRI Bio, Inc. | 5.03M | 18.34% | 494,526 | - |
| 578 | SILO | Silo Pharma, Inc. | 4.96M | -5.72% | 142,860 | 72.10K |
| 579 | ASBP | Aspire Biopharma Holdings, Inc. | 4.87M | -0.81% | 14,780,273 | 1.94K |
| 580 | CDIO | Cardio Diagnostics Holdings, Inc. | 4.87M | 4.14% | 31,972 | 15.78K |
| 581 | JAGX | Jaguar Health, Inc. | 4.67M | -7.41% | 84,807 | 11.79M |
| 582 | KALA | KALA BIO, Inc. | 4.46M | 0.28% | 91,365 | - |
| 583 | GLMD | Galmed Pharmaceuticals Ltd. | 4.44M | -14.02% | 717,609 | - |
| 584 | AIXC | AIxCrypto Holdings, Inc. | 4.39M | -10.07% | 155,532 | - |
| 585 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.09M | -5.18% | 25,126 | 1.36M |
| 586 | OGEN | Oragenics, Inc. | 4.08M | -1.80% | 69,381 | - |
| 587 | HCWB | HCW Biologics Inc. | 3.97M | -7.65% | 63,253 | 422.03K |
| 588 | ENTO | Entero Therapeutics, Inc. | 3.88M | -20.78% | 114,059 | - |
| 589 | PBM | Psyence Biomedical Ltd. | 3.80M | -27.24% | 19,300,576 | - |
| 590 | SPRC | SciSparc Ltd. | 3.78M | -5.28% | 14,789 | 927.00K |
| 591 | PTIX | Protagenic Therapeutics, Inc. | 3.75M | -2.97% | 33,449 | - |
| 592 | CNSP | CNS Pharmaceuticals, Inc. | 3.73M | -3.57% | 3,281 | - |
| 593 | BGMS | Bio Green Med Solution, Inc. | 3.70M | -2.33% | 20,978 | 81.00K |
| 594 | ELAB | PMGC Holdings Inc. | 3.66M | -1.02% | 58,419 | -241.53K |
| 595 | ONCO | Onconetix, Inc. | 3.46M | -7.15% | 6,465 | 1.22M |
| 596 | ARTL | Artelo Biosciences, Inc. | 3.37M | -9.73% | 28,535 | - |
| 597 | ENVB | Enveric Biosciences, Inc. | 3.21M | 6.16% | 29,003 | - |
| 598 | XRTX | XORTX Therapeutics Inc. | 3.13M | -0.02% | 36,875 | - |
| 599 | AZTR | Azitra, Inc. | 3.11M | -7.58% | 243,679 | 7.50K |
| 600 | SLRX | Salarius Pharmaceuticals, Inc. | 3.11M | -6.61% | 471,055 | - |
| 601 | KTTA | Pasithea Therapeutics Corp. | 3.05M | -13.83% | 832,930 | - |
| 602 | SCNI | Scinai Immunotherapeutics Ltd. | 2.96M | -5.99% | 9,449 | 1.15M |
| 603 | CDT | CDT Equity Inc. | 2.77M | -2.30% | 31,603 | - |
| 604 | BDRX | Biodexa Pharmaceuticals Plc | 2.53M | 5.96% | 27,226 | 104.90K |
| 605 | MLEC | Moolec Science SA | 2.27M | 0.30% | 55,702 | 7.83M |
| 606 | INDP | Indaptus Therapeutics, Inc. | 1.99M | -13.04% | 80,530 | - |
| 607 | VRAX | Virax Biolabs Group Limited | 1.87M | -2.11% | 84,414 | 6.33K |
| 608 | DRMA | Dermata Therapeutics, Inc. | 1.64M | -1.64% | 53,674 | - |
| 609 | SLXN | Silexion Therapeutics Corp | 1.39M | 0.66% | 10,206 | - |
| 610 | CMND | Clearmind Medicine Inc. | 1.13M | 2.22% | 6,123,110 | - |
| 611 | ADTX | Aditxt, Inc. | 132.12K | -13.79% | 67,189 | 5.95K |